Cargando…
Results of a randomized and controlled clinical trial evaluating the efficacy and safety of combination therapy with Endostar and S-1 combined with oxaliplatin in advanced gastric cancer
OBJECTIVES: We aimed to evaluate the efficacy and safety of combination therapy of Endostar (recombinant human endostatin) and S-1 combined with oxaliplatin (SOX) in patients with advanced gastric cancer. METHODS: In this randomized, controlled trial, 165 late-stage gastric cancer patients were assi...
Autores principales: | Xu, Rong, Ma, Nan, Wang, Fang, Ma, Lei, Chen, Rui, Chen, Ru, Kebinu, Mijiti, Ma, Lili, Han, Zhongcheng, Ayixiamu, Mayier, Mahemiti, Su, Pengcheng, Naman, Yiming, Jieensi, Haliyazimu, Yang, Haixuan, Adili, Abulizi, Aili, Saiding, Liu, Jiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3728266/ https://www.ncbi.nlm.nih.gov/pubmed/23926435 http://dx.doi.org/10.2147/OTT.S46487 |
Ejemplares similares
-
Curative effect of endostar combined with oxaliplatin in the treatment of primary hepatic carcinoma and its influence on immune cells
por: Lei, Changjiang, et al.
Publicado: (2019) -
Efficacy and toxicities of gemcitabine and cisplatin combined with endostar in advanced thymoma and thymic carcinoma
por: Wang, Yang, et al.
Publicado: (2018) -
Synergistic Antitumor Effects of Endostar in Combination with Oxaliplatin via Inhibition of HIF and CXCR4 in the Colorectal Cell Line SW1116
por: Jin, Fengyan, et al.
Publicado: (2012) -
Inhibitory effect of endostar combined with radiotherapy on gastric cancer animal models
por: Chen, Qitian, et al.
Publicado: (2020) -
Endostar, an Antiangiogenesis Inhibitor, Combined With Chemoradiotherapy for Locally Advanced Cervical Cancer
por: Lu, Heming, et al.
Publicado: (2022)